A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years
NCT02269475 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1369
Last updated 2017-04-04
Summary
The study is designed to gather the efficacy, safety and tolerability data in Japanese children 7 to 18 years of age that would support approval of MEDI3250 in Japan.
Conditions
- Healthy Japanese Children Age 7 Years Through 18 Years
Interventions
- DRUG
-
MEDI3250
MEDI3250
- DRUG
-
Placebo
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Masaki Yokohama, MD · Yokohama clinic
-
Toshiko Yamaguchi, MD · Yamaguchi Clinic
-
Haruo Maeta, MD · Maeta Pediatrics Clinic
-
Hideki Nakazawa, MD · HIGASHIKATSUYAMA nakazawa Naika allergy Internal Medicine
-
Atsushi Shibasaki, MD · Shibasaki internal medicine & Pediatrics Clinic
-
Yutaka Igarashi, MD · Igarashi Children's Clinic
-
Keiko Mitamura, MD · Eiju General Hospital
-
Satoshi Yamada, MD · Kyouai Clinic
-
Kiyoshi Niwa, MD · Niwa Family Clinic
-
Ryuta Ono, MD · Kanagawa HImawari Clinic
-
Eiji Kato, MD · Fukuiken Saiseikai Hospital
-
Toshikazu Takahashi, MD · Takahashi Clinic
-
Ryouta Yoshimura, MD · Yoshimura Children's Clinic
-
Hiroshi Taniguchi, MD · Taniguchi Pediatrics Clinic
-
Hidehisa Shinohara, MD · Shinohara Pediatrics Clinic
-
Michiko Tanabe, MD · Tanabe Pediatrics Clinic
-
Haruo Kuroki, MD · Sotobo Children's Clinic
-
Hirokazu Sato, MD · Sunrise Children's Clinic
-
Katsumi Yamada, MD · Yamada Clinic
-
Hiroshi Sakiyama, MD · Sakiyama Pediatric Clinic
-
Hiroji Okawa, MD · Okawa Children & Family Clinic
-
Junichi Ito, MD · Ito ENT Clinic
-
Masato Morimoto, MD · MORIMOTO ENT CLINIC
-
Masakazu Umemoto, MD · Umemoto Pediatric Clinic
-
Tadashi Matuda, MD · Matsuda Pediatrics Clinic
-
Sadayoshi Torigoe, MD · Aquair Medical Station
-
Shigeru Mori, MD · Momotaro Clinic
-
Yutaka Fujimaki, MD · Fujimaki Ent Clinic
-
Masaki Kato, MD · Kato Ear Nose Throat Clinic
-
Hisakuni Sekino, MD · Sekino Hospital
-
Toshikazu Nagakura, MD · Yoga Allergy Clinic
-
Ichiro Ogiwara, MD · Ogiwara Ent Clinic
-
Akitoshi Funato, MD · Medical corporation Seisyuukai Funato Clinic
-
Naohisa Hoshino, MD · Medical corporation Ryoshukai Kanauchi Medical Clinic
-
Munechika Noguchi, MD · Social medical corporation IHL ShinagawaEastOne Medical Clinic
-
Chiaki Noguchi, MD · Shinkoiwa Ekimae Sougou Clinic
-
Kimihiko Yukisada, MD · Yukisada Clinic for internal disease
-
Hiroshi Shimomura, MD · Medical corporation Junyokai Musashino General Clinic
-
Mitsuhiro Nemoto, MD · Nemoto-geka-seikeigeka
-
Naoki Kawai, MD · Kawai Naika Iin
-
Shigehiro Yazima, MD · Yajima Children's Clinic
-
Tetsuhiko Nagao, MD · Midorino Clinic
-
Kenjiro Nakamura, MD · Tenjin Sogo Clinic
-
Wataru Ikematsu, MD · Kobori Building Clinic
-
Shiro Kimura, MD · Kimura Shiro Clinic
-
Mieko Ueda, MD · Ueda Naika Clinic
-
Minako Iwaya, MD · Iwaya Children's Clinic
-
Motohisa Ikeda, MD · Ikeda Naika Clinic
-
Tetsunari Maeda, MD · Sakura Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
Countries
- Japan
Study Locations
More Related Trials
-
A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults
NCT03597217 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers
NCT02005211 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
NCT07222254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
NCT02209506 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects
NCT00766012 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese
NCT00818129 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.
NCT06519968 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.
NCT06093542 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants
NCT05932641 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants
NCT04863417 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects
NCT02500953 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
NCT06368440 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects
NCT01175564 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants
NCT05070312 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
NCT04878471 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers
NCT01233830 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
NCT02176252 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Doses of AZD1981 in Japan
NCT00698282 ·Status: COMPLETED ·Phase: PHASE1
-
PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants
NCT02306915 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers
NCT00754715 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers
NCT04994106 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry
NCT05351047 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants
NCT02398591 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.
NCT02018536 ·Status: COMPLETED ·Phase: PHASE1